Marko Djerek

Title: Marko Djerek: Innovator in Macrolide Research

Introduction

Marko Djerek is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides and their derivatives. With a total of 2 patents, his work has implications for the treatment of bacterial infections in both humans and animals.

Latest Patents

Djerek's latest patents include innovative formulations and processes. One of his key inventions relates to 14 or 15 membered macrolides substituted at the 4' position, which are designed for therapeutic use against systemic or topical bacterial infections. Another important patent involves derivatives of 3-deoxy-desmycosin, detailing a complex process that includes oxidation, hydrogenation, and epoxidation reactions. These advancements showcase his expertise in pharmaceutical chemistry and his commitment to improving healthcare solutions.

Career Highlights

Throughout his career, Marko Djerek has worked with prominent companies in the pharmaceutical industry. He has been associated with Glaxo Group Limited and Pliva D.d., where he has contributed to various research and development projects. His experience in these organizations has allowed him to refine his skills and expand his knowledge in drug formulation and development.

Collaborations

Marko has collaborated with several professionals in his field, including Suleman Alihodzic and Daniele Andreotti. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Marko Djerek stands out as an influential inventor in the pharmaceutical sector, with a focus on macrolides and their derivatives. His patents reflect a dedication to advancing medical treatments and improving patient outcomes.